Patients who stop taking cholesterol-lowering drugs within a year of surviving a stroke had a two-fold increased risk of death, researchers reported in Stroke: Journal of the American Heart Association.
Scientists have developed a new method of capturing a complete genome-wide screening of blood vessel cells in their actual disease state, advancing the potential for genetic research on the tissue responsible for delivering nourishment that can accelerate the growth of both a cancer tumor or wound healing.
Sleep disorder and ear, nose and throat specialists at Thomas Jefferson University are examining an innovative procedure to treat obstructive sleep apnea syndrome.
Cigarette pack warning labels with prominent text and graphic pictures of smoking damage are most effective at changing smokers’ behavior. Images highlighting the dangers of smoking will be printed on all tobacco products sold in the UK by the end of 2009, under regulations being set out.
In the largest study of its kind, Mayo Clinic researchers have shown that women who had one or both ovaries removed before menopause faced an increased long-term risk of cognitive impairment or dementia, compared to women who retained their ovaries.
The U.S. Food and Drug Administration announced approval of a second test for the detection of West Nile virus (WNV) in blood and organs.
Last week, Jamba Juice was informed by the Santa Clara County Department of Public Health that an employee at San Jose/Willow Glen store has recently been diagnosed and treated for Hepatitis A, the mildest form of Hepatitis.
A landmark study by University of Western Sydney researchers has found people over 50 who take calcium supplements suffer fewer fractures and enjoy a better quality of life.
Vioxx and related pain medications were taken off the market in 2004 because they caused dangerous heart problems in some people. A group of scientists, led by Timothy Hla at the University of Connecticut, may now have figured out how these drugs trigger these life-threatening side-effects.
University of Minnesota researchers have discovered that treating people who have early cardiovascular abnormalities, but show no symptoms of cardiovascular disease, can slow progression and even reverse damage to the heart and blood vessels.